Nanotechnology Now - News Story: "Arrowhead Accelerates Capital Contribution to Insert Therapeutics"

Home > News > Arrowhead Accelerates Capital Contribution to Insert Therapeutics

October 11th, 2005

Arrowhead Accelerates Capital Contribution to Insert Therapeutics

Abstract:
Arrowhead Research Corp. has accelerated its investment of an additional $3 million to majority-owned subsidiary Insert Therapeutics, Inc.

Source:
businesswire

Bookmark:

Related News Press

Investments/IPO's/Splits

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013

Nanometrics Announces Upcoming Investor Events May 14th, 2013

Nanomedicine

Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013

Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013

Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Announcements

Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013

International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013

Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013

Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013